Methasone

Quick links to important sections

Methasone

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Methasone

Quick Facts

Property Description
Active Ingredients Betamethasone Dipropionate, Crotamiton, Dexamethasone
Form Topical Preparation (Cream, Ointment, or Solution)
Pharmacological Class Topical Corticosteroid, Scabicidal Agent, Antipruritic Agent
Common Type Combination Drug
Origin Synthetic

What is Methasone?

Methasone is a synthetic, multicomponent topical medicine designed exclusively for dermal/cutaneous application to the skin in pharmaceutical preparations such as a cream, ointment, or solution. It is classified as a combination drug because it contains three distinct active ingredients: the potent glucocorticoids Betamethasone Dipropionate and Dexamethasone, and the compound Crotamiton. This formulation is intended for complex dermatological issues requiring simultaneous anti-inflammatory, antipruritic, and scabicidal action, a multi-modal approach clinically recognized for addressing conditions where severe inflammation is compounded by intense itching and a potential parasitic trigger.


What Type of Medicine is Methasone?

Methasone is fundamentally defined by the pharmacological classes of its active components, which are all synthetic in origin. The primary components, Betamethasone Dipropionate and Dexamethasone, belong to the class of Topical Corticosteroids (specifically, Glucocorticoids), which are compounds that powerfully reduce inflammation. The third ingredient, Crotamiton, is categorized as both a Scabicidal Agent and an Antipruritic Agent. Crotamiton is used to relieve itching in various skin conditions. This multi-active composition places Methasone in a therapeutic category reserved for conditions requiring more than a standard anti-inflammatory alone.


What is the Purpose of Methasone’s Combination Components?

The general therapeutic purpose of Methasone's specific composition is to achieve rapid, comprehensive control over severe skin irritation and related symptoms. The dual presence of powerful glucocorticoids ensures strong suppression of the inflammatory response, quickly reducing the associated redness, heat, and swelling common in severe skin conditions. Simultaneously, the Crotamiton component works to relieve intense pruritus and, as a scabicidal agent, helps eradicate the Sarcoptes scabiei mite, making the formulation effective for conditions where a parasitic infestation is a contributing factor.

What side effects are possible with Methasone?

Possible Side Effects and Safety Information

Methasone's safety profile is formally documented by regulatory authorities (e.g., FDA, EMA) based on the known characteristics of its potent topical corticosteroid and scabicidal components. Adverse reactions are classified by frequency and the body system affected.

Frequency and System-Organ Classification

The majority of documented adverse effects are local skin reactions. These may include common reactions such as a burning sensation, skin irritation, pruritus, and dryness—often noted as being more frequent at the start of treatment. Uncommon effects include follicular disorders like folliculitis and acneiform eruptions, as well as changes in skin pigmentation (hypopigmentation).

Serious and Exposure-Related Reactions

Rare but clinically significant adverse reactions include skin atrophy (thinning), striae (stretch marks), and telangiectasia (spider veins), which are primarily associated with prolonged or extensive use of potent corticosteroids. The most serious systemic risks, classified as having a frequency not known, are Adrenal suppression (HPA axis suppression) and Cushing's syndrome, which occur due to high absorption.

System-Organ Class Examples of Documented Reactions
Skin and Subcutaneous Tissue Irritation, Atrophy, Striae, Folliculitis
Endocrine Disorders HPA axis suppression, Cushing's syndrome
Eye Disorders Glaucoma, Cataracts (if applied near eyes)

Population-Specific Safety Notes

The regulatory profile notes that pediatric patients (children and infants) are officially recognized as being more susceptible to systemic toxicity (e.g., HPA axis suppression) due to their increased skin surface area-to-body weight ratio. The label imposes high-level safety constraints regarding application, explicitly restricting use under occlusive dressings or on large surface areas to mitigate the documented risk of systemic absorption.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Methasone is a life-threatening medical emergency. The critical danger is severe respiratory depression, which can be fatal. If an overdose is suspected, emergency medical help must be sought immediately by calling 911 (or local emergency services) without delay, even if symptoms are not fully apparent or if the available antidote has been administered.

Signs of a Methasone overdose typically involve a triad of physiological effects:

  • Respiratory Depression: Shallow or significantly slowed breathing that may progress to cessation (apnoea).
  • Central Nervous System Depression: Extreme sleepiness (somnolence) that advances to stupor or coma (unresponsiveness).
  • Miosis: Pinpoint pupils, although pupil dilation may occur due to severe oxygen deprivation (hypoxia).

Other serious manifestations can include marked hypotension (low blood pressure), slow heart rate (bradycardia), muscle flaccidity, and potentially serious cardiac arrhythmia such as QT prolongation. Accidental ingestion of even a single dose, particularly by a child, is recognized as a cause of fatal overdose.

Due to the drug's extended duration of action, the depressant effects can persist longer than the available antidote (naloxone), requiring continuous monitoring and potentially repeated administration of the antidote in a specialized medical setting to prevent relapse into respiratory depression. Management focuses on re-establishing a clear airway and providing assisted ventilation.

Therapeutic Uses of Methasone

What Methasone treats: Main Uses and Benefits

Methasone is a combination topical formulation that may be part of symptomatic management for specific, conditions characterized by periods of heightened symptoms, where inflammation, intense itching, and potential parasitic involvement are key features. Given the profile of its scabicidal component, the product is commonly used for the symptomatic management of pruritic skin.

Therapeutic Applications

Methasone is relevant for easing symptoms associated with conditions such as scabies, recurrent eczema, dermatitis, and psoriasis. This combination is applied in contexts requiring a multi-modal approach to manage multiple symptoms appearing suddenly or fluctuating over time. It helps address symptoms related to inflammatory or irritative states and provides relief from symptoms that interfere with daily comfort.

“The primary therapeutic benefit involves the management of symptoms related to parasitic infestation and supports the patient during the resulting acute skin reaction, assists with maintaining comfort.”

Quick Fact: Relief for Acute Distress

Therapeutic Focus Symptoms Managed Patient Benefit
Multi-Modal Relief Parasitic triggers, intense itching, swelling, and redness. Contributes to easing the overall symptom load.
Acute Support Heightened physiological activity and disruptive symptom patterns. Supports patients during episodes of heightened discomfort.
Chronic Care Flare-ups of eczema, psoriasis, and dermatitis. Supports the patient during difficult episodes by easing distress.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Methasone

Methasone's eligibility is determined by the regulatory profile of its potent corticosteroid and scabicidal components, establishing strict prohibitions and use limitations.

Category Official Regulatory Statement
Populations for whom use is contraindicated Patients with known hypersensitivity to any component. Presence of primary skin infections (viral, fungal, bacterial), rosacea, or perioral dermatitis.
Age-related eligibility rules Contraindicated in infants (typically under one year of age). Use in children is restricted to the shortest possible duration and smallest area due to heightened risk of systemic effects.
Pregnancy and lactation eligibility status Not Recommended during pregnancy or lactation unless conditional use is necessary. Use should not be extensive; avoid application on the breast area while nursing.
Eligibility-related restrictions Use is strictly limited to small skin areas and the shortest possible duration. Must not be applied to ulcerative lesions or open wounds.

Connection to the overall eligibility profile: Regulatory documents define Methasone eligibility primarily by excluding populations where its potent components present an unacceptable risk, especially concerning systemic absorption. Eligibility is conditional upon the absence of formal contraindications and strict adherence to limitations on application area and duration, as explicitly defined in government labeling.

What should I know about interactions with other medicines?

Methasone Interactions with other medicines and products

Methasone (related to Dexamethasone) is a potent corticosteroid whose use requires careful consideration of potential interactions with other medicinal products. These interactions are primarily classified as clinically significant and necessitate dose adjustments or, in certain cases, are contraindicated.

Methasone is metabolized by and is an inducer of the liver enzyme Cytochrome P450 3A4 (CYP3A4). Therefore, strong inhibitors of CYP3A4 (e.g., certain antifungal and antibiotic medicines) may increase Methasone levels in the body, raising the risk of side effects. Conversely, strong inducers of CYP3A4 (e.g., certain anti-seizure medicines and Rifampicin) may decrease Methasone levels, potentially leading to reduced effectiveness. Concomitant use with these classes often requires close monitoring or avoidance.

The drug's metabolic effects are also a source of interaction. By increasing blood glucose levels, Methasone can reduce the therapeutic efficacy of antidiabetic drugs, requiring an upward adjustment in the dose of the antidiabetic regimen. Combination with Nonsteroidal Anti-inflammatory Drugs (NSAIDs) may elevate the risk of gastrointestinal ulceration or bleeding.

Interaction-Related Restrictions

Administration of live or live attenuated vaccines is generally contraindicated in patients receiving immunosuppressive doses of Methasone due to the risk of vaccine-related infection. Additionally, when co-administering Methasone with Levothyroxine, the corticosteroid should be started before Levothyroxine to manage the risk of acute adrenal crisis.

Mechanism of Action

Methasone is a glucocorticoid receptor agonist.

Its mechanism involves rapid passive diffusion across the cell membrane to bind to the cytosolic glucocorticoid receptor (GR). The activated receptor-drug complex then translocates into the nucleus and interacts with DNA at glucocorticoid response elements (GREs).

This binding alters the transcription of target genes, primarily leading to the repression of pro-inflammatory genes and the induction of anti-inflammatory genes. This action results in the inhibition of key inflammatory mediators, including cytokines such as IL-6 and TNF-alpha, and chemokines.

Further downstream, Methasone influences the function of immune cells, including mast cells and eosinophils. The mechanism also involves selectively promoting the expression of osteoprotegerin (OPG) over RANKL, impacting physiological pathways related to bone cell activity. The drug's activity proceeds through both genomic (transcriptional) and non-genomic pathways.

Dosage and Administration Information

How to Use Methasone

Methasone is a combination topical medication whose usage is strictly governed by protocols established for its potent corticosteroid components, primarily Betamethasone Dipropionate. The instructions define a highly constrained, short-term application protocol to minimize systemic exposure.

Administration Protocol

The route of administration for Methasone is Topical application to the skin. It is available in forms such as a cream, ointment, or solution.

Instruction Entity Guideline
Application Apply a thin film of the preparation to the affected area.
Frequency Application is typically restricted to once daily or twice daily.
Dose Limit The total quantity used must not exceed 50 grams per week.
Duration Treatment should be discontinued upon achieving control and must not exceed 2 consecutive weeks.

Administration Conditions and Restrictions

Specific administration constraints are set to ensure proper usage. Methasone is for external use only and application must be avoided on sensitive areas, including the face, groin, or axillae. Patients are instructed not to use occlusive dressings (bandages or wraps) over the treated area. In pediatric patients, the product should be administered using the least amount of medicine compatible with the required usage to account for the potential for higher systemic absorption.

Recent Clinical Evidence

Methasone: Recent Clinical Evidence

Evidence for Inflammatory Dermatoses

Research exploring the anti-inflammatory components of Methasone is based primarily on Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies monitored outcomes linked to inflammatory or irritative states common in conditions like eczema and psoriasis. Researchers typically measured changes in physical signs of inflammation and patient-reported outcomes describing perceived discomfort, like itching. The studies focused on adults and specific pediatric groups who had conditions characterized by fluctuating or episodic manifestations.

Findings describe patterns observed where measured disease severity scores evolved during the short-term trial periods. Some research reported that the anti-inflammatory component’s measurements were distinct when compared to the inactive preparation base (vehicle). This information contributes to understanding symptom patterns over the duration of the trials.

Evidence for Parasitic and Pruritic Conditions

Evidence for the scabicidal component was studied for conditions involving periods of heightened symptoms, specifically scabies. Research consisted of Comparative Clinical Trials and RCTs which explored two main outcomes: clinical clearance rates of the infestation and relief of patient-reported outcomes (itching). Data show patterns related to the measured resolution rates when the component was evaluated as a single treatment.

Comparative trials reported that the resolution rate was associated with variability when its performance was measured against other established topical scabicides. Evidence is limited regarding the full therapeutic role of this specific three-component combination product.

Research Limitations and Uncertainty

The follow-up durations were limited for many core trials, meaning long-term effects are not fully established regarding chronic management or recurrence prevention. There is limited information for long-term outcomes that measure the persistence of any observed changes. Additionally, limited specific research was studied for the exact combination product containing all three active ingredients. Subgroup findings are uncertain in some areas due to modest sample sizes in certain groups.

Findings describe group patterns, not personal outcomes, and research does not determine whether an individual will respond similarly. The overall body of evidence highlights what is known—and what is still uncertain.

Frequently Asked Questions (FAQ)

Common questions about Methasone (FAQ)

Q: What is the difference between Methasone and Dexamethasone?

Methasone is defined in regulatory documents as a combination topical product that includes Dexamethasone as one of its three active ingredients. Methasone's formulation addresses dermatological conditions where the combined pharmacological action of its three ingredients is utilized.

Q: How is Methasone different from Prednisone?

Methasone is classified as a topical medicine intended only for application to the skin. Prednisone, by contrast, is generally classified as an oral corticosteroid used for systemic (body-wide) conditions. Although both belong to the glucocorticoid class of medicines, their specific routes of administration and regulatory uses are distinct.

Q: Why do doctors prescribe Methasone for so many different conditions?

The medicine is prescribed for conditions requiring a multi-faceted approach, according to its official indications. Its use in various skin conditions is linked to the combined action of its three components, which provide strong anti-inflammatory action (from the glucocorticoids Betamethasone and Dexamethasone) along with anti-itch and scabicidal (mite-killing) actions from Crotamiton.

Q: Can Methasone affect my sleep?

Official product information for corticosteroids notes that sleep problems, such as insomnia, have been documented as potential side effects. These effects are generally associated with the systemic absorption of glucocorticoids, the medicine class to which Methasone's potent ingredients belong.

Q: Is it common to feel tired while taking Methasone?

Regulatory warnings indicate that unusual tiredness or weakness can be a symptom linked to certain serious, exposure-related side effects. Specifically, these may be signs of adrenal gland problems, known as HPA axis suppression, which are typically only seen with high systemic exposure.

Q: Why must Methasone be reduced slowly?

Regulatory guidance for potent corticosteroids advises a gradual reduction or slow stopping of the medicine when used for prolonged periods. Regulatory guidance states that this measure is intended to support the gradual recovery of the body’s natural cortisol production and minimize the risk of adrenal insufficiency.

Q: What are the signs of Methasone withdrawal?

Regulatory documents list symptoms associated with adrenal gland suppression (HPA axis suppression), which may occur when potent corticosteroids are stopped. These symptoms can include general issues like tiredness, weakness, loss of appetite, and mood changes.

Q: Can Methasone make you feel anxious or moody?

Mood and behavior changes, including feelings of anxiety or emotional instability, are known potential side effects associated with the systemic exposure of glucocorticoid medicines. These effects are documented in official safety profiles.

Q: Is it possible to be allergic to Methasone?

Yes. According to official regulatory information, the product is contraindicated, meaning it should not be used, in patients who have a known hypersensitivity (allergic reaction) to any of its active or inactive ingredients.

Q: What are the general expectations for the duration of Methasone treatment?

Treatment duration is formally restricted to be as short as possible and typically must not exceed 2 consecutive weeks, according to regulatory guidelines. This short duration reflects its intended use for achieving rapid control of a condition.

Q: Does Methasone cause weight gain?

Weight gain and increased appetite are documented side effects associated with the systemic absorption of glucocorticoids. This information comes from the official adverse reactions profiles of the medicine class to which Methasone's potent ingredients belong.

Q: How long does Methasone stay in your system?

The length of time its active components remain in the system depends on the degree of absorption into the body. The biological half-life (the time it takes for half the drug to be eliminated) of its primary glucocorticoid components is described in pharmacokinetics data as ranging from several hours up to a day or more.

Q: Can Methasone cause headaches?

Headaches are listed in official regulatory documents as a potential side effect. This has been reported in association with the use of glucocorticoid medicines.

Q: Does Methasone affect fertility in men or women?

Official regulatory information for its glucocorticoid components, such as Dexamethasone, does not currently indicate that their use is known to affect fertility in men or women.

Q: Can I take Methasone if I have high blood pressure?

High blood pressure (hypertension) is listed in regulatory documents as a condition that may require caution or monitoring during the use of glucocorticoid medicines. This caution is due to the potential for systemic absorption to affect blood pressure.

Q: How long after taking Methasone can I expect to feel better?

Glucocorticoid medicines generally have a rapid onset of their anti-inflammatory effect on the skin following application. Research has typically measured changes in disease severity scores over short-term trial periods to track how symptoms evolve.

Q: Can Methasone affect my blood pressure?

Increases in blood pressure have been documented in regulatory safety profiles as a potential side effect associated with the systemic absorption of its glucocorticoid components.

Q: Can Methasone cause stomach problems?

Gastrointestinal effects, including general stomach problems (like nausea and abdominal distension), are documented potential side effects. These effects are associated with the systemic exposure of glucocorticoid medicines.

Q: Can Methasone interact with herbal supplements?

Official regulatory information typically advises patients to inform their healthcare provider about all prescription, over-the-counter, and herbal supplements they are taking. This is general guidance due to the potential for undocumented interactions.

How should Methasone be stored and disposed of?

Methasone (topical) must be stored strictly according to official regulatory requirements to maintain its stability and potency.

Storage Conditions

Methasone must be kept at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The product must be protected from excessive heat and moisture and must not be frozen. Keep the container tightly closed and in its original packaging.

Child Safety and Disposal

It is mandatory to store the medicine out of the sight and reach of children. Unused or expired Methasone must be disposed of according to local regulations. The medicine should not be poured down a sink or toilet; instead, follow official government guidelines, which typically recommend mixing it with an unappealing substance and sealing it before placing it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Methasone found in:

A-Z Index: